ZZM-1220, a covalent inhibitor of histone lysine methyltransferase G9a/GLP, exhibits IC50 values of 458 nM for G9a and 924 nM for GLP. It effectively inhibits H3K9me2 in cells, induces apoptosis in triple-negative breast cancer (TNBC) cells, and arrests the cell cycle at the G2/M phase [1].
Molecular Weight:
447.53
Formula:
C25H29N5O3
Target:
Histone Methyltransferase|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
